Karan Malhotra1, Jan L Marciniak2, Sandra J Bonczek2, Neil Hunt2. 1. Department of Orthopaedics, York Teaching Hospital NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK. karan@doctors.org.uk. 2. Department of Orthopaedics, York Teaching Hospital NHS Foundation Trust, Wigginton Road, York, YO31 8HE, UK.
Abstract
BACKGROUND: Venous thromboembolism (VTE) is a significant complication of lower limb arthroplasty. The National Institute for Health and Care Excellence recommends routine use of chemical and mechanical prophylaxis to prevent VTE. Our high-volume, elective, arthroplasty unit adopted this guidance in 2008. PURPOSE: We examined our incidence of VTE before and after introduction of chemical thromboprophylaxis to determine whether the incidence of VTE reduced. METHODS: We retrospectively gathered data on 2 cohorts of patients-from January 2004 to August 2007 (Group 1) and January 2010 to December 2012 (Group 2). Patients in Group 1 received mechanical prophylaxis only (unless particularly high risk for VTE), and patients in Group 2 received mechanical and chemical prophylaxis. We recorded VTE occurring within 6 months of surgery. Patients in Group 1 receiving chemical prophylaxis were excluded. RESULTS: Group 1 had 2320 cases of primary and revision lower limb arthroplasty, and Group 2 had 1430 cases. VTE occurred in 37 cases in Group 1 (1.6 %), and in 17 cases in Group 2 (1.2 %). This difference was not statistically significant (p = 0.26). In Group 1, 1 patient died within 6 months due to pulmonary embolism (0.04 %); there were no VTE-related deaths in Group 2 (0 %). This was also not statistically significant (p = 0.06). CONCLUSIONS: Although our VTE rate reduced by 0.4 % and our VTE-related mortality reduced by 0.04 % after introduction of chemical thromboprophylaxis, these differences were not statistically significant. Chemical thromboprophylaxis may not be required in all patients undergoing arthroplasty providing appropriate mechanical prophylaxis is used.
BACKGROUND:Venous thromboembolism (VTE) is a significant complication of lower limb arthroplasty. The National Institute for Health and Care Excellence recommends routine use of chemical and mechanical prophylaxis to prevent VTE. Our high-volume, elective, arthroplasty unit adopted this guidance in 2008. PURPOSE: We examined our incidence of VTE before and after introduction of chemical thromboprophylaxis to determine whether the incidence of VTE reduced. METHODS: We retrospectively gathered data on 2 cohorts of patients-from January 2004 to August 2007 (Group 1) and January 2010 to December 2012 (Group 2). Patients in Group 1 received mechanical prophylaxis only (unless particularly high risk for VTE), and patients in Group 2 received mechanical and chemical prophylaxis. We recorded VTE occurring within 6 months of surgery. Patients in Group 1 receiving chemical prophylaxis were excluded. RESULTS: Group 1 had 2320 cases of primary and revision lower limb arthroplasty, and Group 2 had 1430 cases. VTE occurred in 37 cases in Group 1 (1.6 %), and in 17 cases in Group 2 (1.2 %). This difference was not statistically significant (p = 0.26). In Group 1, 1 patient died within 6 months due to pulmonary embolism (0.04 %); there were no VTE-related deaths in Group 2 (0 %). This was also not statistically significant (p = 0.06). CONCLUSIONS: Although our VTE rate reduced by 0.4 % and our VTE-related mortality reduced by 0.04 % after introduction of chemical thromboprophylaxis, these differences were not statistically significant. Chemical thromboprophylaxis may not be required in all patients undergoing arthroplasty providing appropriate mechanical prophylaxis is used.
Entities:
Keywords:
Thromboprophylaxis; Total hip arthroplasty; Total knee arthroplasty; Venous thromboembolism
Authors: Linda P Hunt; Yoav Ben-Shlomo; Emma M Clark; Paul Dieppe; Andrew Judge; Alex J MacGregor; Jon H Tobias; Kelly Vernon; Ashley W Blom Journal: Lancet Date: 2013-09-28 Impact factor: 79.321
Authors: Clifford W Colwell; Mark I Froimson; Michael A Mont; Merrill A Ritter; Robert T Trousdale; Knute C Buehler; Andrew Spitzer; Thomas K Donaldson; Douglas E Padgett Journal: J Bone Joint Surg Am Date: 2010-03 Impact factor: 5.284
Authors: Henrik Husted; Kristian Stahl Otte; Billy B Kristensen; Thue Ørsnes; Christian Wong; Henrik Kehlet Journal: Acta Orthop Date: 2010-10 Impact factor: 3.717